Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age

首页> 外文期刊>Health technology assessment: HTA >Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age

【24h】

Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age

机译：开放标签，随机，平行，多中心研究，以评估AS03B /水包油佐剂（AS03B）分裂病毒与非佐剂全病毒H1N1流感疫苗的安全性，耐受性和免疫原性英国6个月至12岁的儿童

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Health technology assessment: HTA》 |2010年第46期|共页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类放射卫生;
关键词

相似文献

外文文献
中文文献

1. Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. [J] . Waddington C, Andrews N, Hoschler K, Health technology assessment: HTA . 2010,第46期

机译：开放标签，随机分组，平行组，多中心研究，以评估AS03（B）/水包油乳化佐剂（AS03（B））分裂病毒颗粒与非佐剂全病毒制剂的安全性，耐受性和免疫原性virion H1N1流感疫苗在英国6个月至12岁的儿童中使用。
2. Safety and Immunogenicity of a Full-dose, Split-virion, Inactivated, Quadrivalent Influenza Vaccine in Healthy Children 6-35 Months of Age A Randomized Controlled Clinical Trial [J] . Robertson Corwin A., Mercer Monica, Selmani Alexandre, The Pediatric infectious disease journal . 2019,第3期

机译：全剂量，分裂病毒，灭活，在健康儿童中灭活，四分之一流感疫苗的安全性和免疫原性6-35个月的随机对照临床试验
3. Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine Two Open-label, Randomized Trials [J] . Vesikari Timo, Richardus Jan Hendrik, Berglund Johan, The Pediatric infectious disease journal . 2015,第7期

机译：6个月至17岁儿童三价灭活流感疫苗的免疫原性和安全性，此前曾接种过AS03佐剂的A（H1N1）Pdm09疫苗两个开放标签的随机试验
4. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label randomised parallel group multicentre study [O] . Claire S Waddington, W T Walker, C Oeser, 2010

机译：在英国的6个月至12岁儿童中AS03B联合分裂病毒粒子与非佐剂完整病毒粒子H1N1流感疫苗的安全性和免疫原性：开放标签随机分组平行分组多中心研究
5. Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. [O] . Waddington, C, Andrews, N, Hoschler, K, 2010

机译：开放标签，随机分组，平行组，多中心研究，以评估AS03（B）/水包油乳化佐剂（AS03（B））分割病毒体与非佐剂全乳剂的安全性，耐受性和免疫原性virion H1N1流感疫苗在6个月至12岁的英国儿童中使用。

Open Label, Randomized, Parallel-Group, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B /oil-in-water emulsion-adjuvanted (AS03B) split-virion vs. non-adjuvanted whole virion H1N1 influenza vaccine in UK children 6 months to 12 years of age

著录项

相似文献

相关主题

期刊订阅